Chemokine receptor antagonism as a new therapy for multiple sclerosis (Q34074854)

30 July 2017

1 reference

title

Chemokine receptor antagonism as a new therapy for multiple sclerosis (English)

1 reference

30 July 2017

0 references

Ransohoff RM

1

1 reference

PubMed ID

11060729

30 July 2017

Bacon KB

series ordinal

2

1 reference

PubMed ID

11060729

30 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

1 reference

30 July 2017

9

1 reference

30 July 2017

1079-1097

1 reference

30 July 2017

5

1 reference

Demyelinating disease: evolution of a paradigm

30 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Progress in determining the causes and treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Genetic epidemiology of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

The genetic epidemiology of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Epidemiology of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Immunopathogenesis of multiple sclerosis: the role of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

The pathology of multiple sclerosis: a historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Effector pathways in immune mediated central nervous system demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Axonal pathology in multiple sclerosis. A historical note.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Axonal damage in acute multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Axonal degeneration in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Mouse models of myelin diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Axonal pathology in multiple sclerosis: relationship to neurologic disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

From enhancing lesions to brain atrophy in relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Chemokines in the CNS: plurifunctional mediators in diverse states

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Chemokines, leukocyte trafficking, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Lymphocyte homing and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Multistep navigation and the combinatorial control of leukocyte chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Chemokines and leukocyte traffic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Chemokines and the arrest of lymphocytes rolling under flow conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

The molecular biology of leukocyte chemoattractant receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Molecular properties of the chemokine receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Properties of the novel proinflammatory supergene "intercrine" cytokine family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Chemokines and cell migration in secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Distinct patterns and kinetics of chemokine production regulate dendritic cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Chemokines in disease models and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Differential blood-brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

The blood-brain barrier and the inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Inflammation in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

The unique characteristics of inflammatory responses in mouse brain are acquired during postnatal development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Kainic acid induced seizures: neurochemical and histopathological changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Recombinant human adenovirus with rat MIP-2 gene insertion causes prolonged PMN recruitment to the murine brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Inflammation in EAE: role of chemokine/cytokine expression by resident and infiltrating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Mechanisms of immune injury in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

The epigenetics of multiple sclerosis: clues to etiology and a rationale for immune therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Chemokines in immune-mediated inflammation of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Migration of Hematogenous Cells Through the Blood-Brain Barrier and the Initiation of CNS Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Transcriptional regulation of chemokine gene expression in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

The CCR5 deletion mutation fails to protect against multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Relevance of platelet factor four (PF4) plasma levels in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Macrophage inflammatory protein-1 alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Chemokine receptor antagonists: novel therapeutics for inflammation and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

Chemokine expression in murine experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1079

10.1517/13543784.9.5.1079

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11060729